Cullinan Oncology, Inc. (CGEM) Misses Q2 EPS by 25c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q2 EPS of ($1.07), $0.25 worse than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Canaccord Starts BillionToOne Inc (BLLN) at Buy
• Credo Tech (CRDO) PT Lowered to $275 at BofA Securities
• Palo Alto Networks (PANW) Tops Q4 EPS by 4c, Offers Guidance